[ad_1]

Low-cost, patient-friendly platforms can improve patient outcomes while reducing healthcare spending

new york, April 2, 2024 /PRNewswire/ — peer bridge healthThe company, the developer of a hospital-grade remote diagnostic platform that uses AI to detect early signs of heart failure, today announced that its technology has nearly 96% accuracy in identifying heart failure in patients using ECGs. We presented the results of a recent feasibility study showing that. Input only.

Patients in the clinical trial wore the company’s AI-enabled Peerbridge Cor™ 3-lead, 2-channel wireless portable ECG patch at home for 3 to 7 days. Leveraging his five-minute window of ECG signals, the Peerbridge platform was able to determine whether an individual patient had heart failure (HFpEF or HFrEF) with 95.7% accuracy.

More than 6 million Americans live with heart failure, and approximately 1 million new cases are diagnosed each year in adults age 55 and older. Heart failure is the second leading cause of hospitalization in the United States (after sepsis) and is the leading cause of hospitalization in adults age 65 and older. 80% of initial diagnoses of heart failure are only discovered after an emergency hospital visit. Fewer than half of these patients survive for more than 5 years.

The Peerbridge Health platform provides seamless home monitoring options, delivering results faster and at a lower cost, reducing patient burden and enabling more frequent assessments. For patients, it can take 11 to 15 weeks to confirm a diagnosis after seeing a cardiologist and testing and contacting your doctor. Peerbridge can provide accurate diagnosis within 30 minutes at a fraction of the cost of traditional diagnostics.

More than 45 million people in the United States have stage B, or asymptomatic, heart failure and don’t know it. Early detection and treatment of heart failure not only saves lives, but also helps avoid costly readmission cycles for heart disease patients, which cost our nation billions of dollars in annual health care costs.

“As a physician, being able to intervene with patients before an emergency visit is a huge opportunity for their health,” said Brian Kolsky, M.D., director of structural heart disease at St. Joseph’s Hospital. Orange County, California, principal investigator of the feasibility study. “It also allows us to inexpensively extend care to patients who are currently unreachable.”

Given the significant shortage of cardiologists, which is expected to worsen in the coming years, and the increasing cost of heart failure to Medicare, it is important that our health care system treat heart failure early, affordably, and universally. It is essential to discover how. The Peerbridge platform provides this simple, patient-friendly solution.

“The current diagnostic process for heart failure is slow and expensive,” said Peerbridge Health CEO and President. chris darland. “We know that early detection saves lives, and our platform is a cost-effective, easy-to-implement solution that quickly and accurately identifies this disease and positively impacts patient outcomes. We offer an easy solution, and we are excited that the feasibility study showed exceptional effectiveness.”

A pivotal trial of the Peerbridge Cor platform is scheduled for the fall. Detailed feasibility study results will be presented at the 2024 Heart Rhythm Conference. May 16th to 19th in boston.

About Peerbridge Health
Peerbridge Health is revolutionizing cardiac care as the first company to bring the quality and accuracy of hospital-grade cardiac diagnostics to the home. The company’s Peerbridge Cor™ AI-enabled device includes a 3-lead patented AECG wearable device that features a design based on the Eindhoven triangle. The Peerbridge platform leverages the ECG to diagnose and monitor the most important elements of cardiac care at a lower cost than ever before. The data collected provides actionable insights that drive early invention, reduce hospital visits, and save lives. For more information, please visit peerbridgehealth.com or our LinkedIn page.

media contact
Amendola at Peer Ridge Health
kim mall
949-322-3733
[email protected]

Source Peerbridge Health

[ad_2]

Source link